|
SMNDC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.81029977067249E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.76229999984778E-08 |
| Normal-vs-Stage2 |
4.10889999802322E-09 |
| Normal-vs-Stage3 |
6.03079997052447E-09 |
| Normal-vs-Stage4 |
4.70440000288619E-08 |
| Stage1-vs-Stage2 |
1.628470E-02 |
| Stage1-vs-Stage3 |
1.036820E-01 |
| Stage1-vs-Stage4 |
1.975240E-01 |
| Stage2-vs-Stage3 |
3.007800E-01 |
| Stage2-vs-Stage4 |
3.399400E-01 |
| Stage3-vs-Stage4 |
9.861800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.59919999465075E-09 |
| Normal-vs-AfricanAmerican |
3.237600E-03 |
| Normal-vs-Asian |
2.1260000000467E-06 |
| Caucasian-vs-AfricanAmerican |
3.673000E-01 |
| Caucasian-vs-Asian |
9.085600E-01 |
| AfricanAmerican-vs-Asian |
4.004000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.45340000035077E-08 |
| Normal-vs-Female |
8.01089972135571E-10 |
| Male-vs-Female |
7.998800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.7568999999561E-06 |
| Normal-vs-Age(41-60Yrs) |
1.51879953058653E-10 |
| Normal-vs-Age(61-80Yrs) |
5.14649989291627E-10 |
| Normal-vs-Age(81-100Yrs) |
1.437680E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.959830E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.444300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.551400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.651200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.646800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.786400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.314400E-01 |
| Classical-VS-Follicular |
1.815850E-02 |
| Classical-VS-Other |
5.138600E-01 |
| Classical-VS-Normal |
1.94289999644326E-08 |
| Tall-VS-Follicular |
2.740000E-01 |
| Tall-VS-Other |
4.839800E-01 |
| Tall-VS-Normal |
2.189700E-04 |
| Follicular-VS-Other |
1.967200E-01 |
| Follicular-VS-Normal |
7.49810002975693E-09 |
| Other-VS-Normal |
1.286960E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.6213036709637E-11 |
| Normal-vs-N1 |
8.18209999975394E-07 |
| N0-vs-N1 |
5.698000E-01 |
|
|
